Home | Welcome to Contract Pharma   
Last Updated Monday, September 1 2014
Print

Search Results for 'Financial Reports'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published May 2, 2014
Esbriet revenues climb 188% Read More »
By Gil Roth
Published February 6, 2014
Generics drive sales down, more layoffs planned Read More »
By Gil Roth
Published February 6, 2014
Diabetes, Genzyme, Generics key drivers Read More »
By Gil Roth
Published February 6, 2014
Generic exclusivity boosts 4Q revenues Read More »
By Gil Roth
Published February 5, 2014
Botox, eye care drugs fuel growth Read More »
By Gil Roth
Published February 5, 2014
Growth pushed by Late-Stage Development segment Read More »
By Gil Roth
Published February 5, 2014
Stribild, Complera/Eviplera drive growth Read More »
By Gil Roth
Published February 5, 2014
Singulair, other patent expirations weigh on revenues Read More »
By Michael Martorelli
Published November 6, 2009
Feel Better Now? Ending one year, approaching the next By Michael A. Martorelli It’s always interesting to write a column about an event that is still in my future, but will have already happened by the time you read my words. Th… Read More »
Published April 16, 2014
Revenues up 3% in the quarter Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On